Academic Interests
Dr. Cintolo Gonzalez’s research focus has primarily been in melanoma. She has performed retrospective analysis of UVM’s management of locoregional melanoma patients and also a prospective study on screening practices and impact on stage of presentation. Dr. Cintolo Gonzalez started the intralesional therapy program with T-VEC and is researching factors associated with response to this treatment as well as strategies for determining continuation or discontinuation of this treatment. She has an IIT assessing accuracy of ctDNA in determining disease status among melanoma patients with a variety of clinical presentations and am working on studies to assess how best to incorporate ctDNA into clinical practice for melanoma patients. She is the local co-PI on a neoadjuvant trial in melanoma and have other clinical trials pending in melanoma. With her colleague, Dr. O'Neill, she started UVM’s peritoneal surface malignancy program and has expanded techniques for disease treatment and palliation. She is working to bring clinical trials for that group of patients. She is part national working groups seeking to improve and expand treatments for retroperitoneal and soft tissue sarcoma. Dr. Cintolo Gonzalez is also involved in the breast oncology transdisciplinary team and has been study the local PI for the COMET trial, which is shaping treatment of low risk DCIS.